Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules

Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules
复制标题

DOI:
10.1210/jc.84.1.24
复制
发表时间:
1999-01-01
影响因子:
5.8
通讯作者:
Aurengo, A
Aurengo, A
中科院分区:
医学2区
文献类型:
--
作者:
Leenhardt, L;Hejblum, G;Aurengo, A

文献摘要

被引文献

相似文献

虽然超声(US)引导下的细针吸取活检(FNAB)被广泛用于不可触及的甲状腺结节,但本研究的目标是精确地确定一系列450个不可触及结节的US-FNAB的适应症和限度。在94例手术对照病例中,20例被诊断为癌(8例小于等于10厘米,12个大于等于等于厘米)。US-FNAB诊断恶性肿瘤16例,3例因细胞学资料不足而漏诊,1例误诊。US-FNAb的敏感性和特异性分别为94%和63%。Logistic模型表明,结节大小(P<0.0003)与组织学诊断无关,但实性低回声特征更有可能是恶性的(P<0.6),US对恶性的敏感性和特异性分别为80%和70%。Logistic回归分析显示,随着结节大小的增加,细胞学材料的充分性显著增加(P<0.0001)。这一结果概述了US-FNAB在小结节中的限度。因此,US-FNAB的指征在厘米或高回声结节或实性和低回声结节中似乎是明智的。这样的管理将允许发现20种癌症中的15种,并将避免16%的不必要的活组织检查。
Although ultrasound (US)-guided fine needle aspiration biopsy (FNAB) is widely prescribed in nonpalpable thyroid nodules, the goal of this study was to define precisely the indications and limits of US-FNAB in a series of 450 nonpalpable nodules. Among 94 surgically controlled cases, 20 (8 infracentimetric and 12 centimetric or supracentimetric) carcinomas were diagnosed. The diagnosis of malignancy was successfully made by US-FNAB in 16 of 20 carcinomas, 3 were missed because of insufficient cytological material, and 1 was misdiagnosed. US-FNAB sensitivity and specificity were 94% and 63%, respectively. A logistic model indicated that nodule size (P < 0.6) was not associated with histological diagnosis, but that solid hypoechoic features mere more likely to be malignant (P < 0.0003), with US sensitivity and specificity for malignancy of 80% and 70%, respectively. Logistic regression indicated that adequate cytological material significantly increased with nodule size (P < 0.0001). This result outlined the limits of US-FNAB in small nodules. Hence, indication of US-FNAB appears judicious in centimetric or supracentimetric nodules or in solid and hypoechoic ones. Such a management would allow the discovery of 15 of 20 carcinomas and would avoid 16% of unnecessary biopsies.